Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Debt Ratio (2016)

Gyre Therapeutics has reported Debt Ratio over the past 7 years, most recently at 0.0 for Q3 2016.

  • Quarterly Debt Ratio fell 94.02% to 0.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was 0.0 through Sep 2016, down 94.02% year-over-year, with the annual reading at 0.02 for FY2015, N/A changed from the prior year.
  • Debt Ratio was 0.0 for Q3 2016 at Gyre Therapeutics, down from 0.0 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.02 in Q4 2015 and troughed at 0.0 in Q3 2016.
  • The 5-year median for Debt Ratio is 0.01 (2013), against an average of 0.01.
  • Year-over-year, Debt Ratio skyrocketed 120.39% in 2015 and then crashed 94.02% in 2016.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2012, then fell by 25.7% to 0.01 in 2013, then crashed by 47.14% to 0.0 in 2014, then skyrocketed by 303.95% to 0.02 in 2015, then crashed by 96.74% to 0.0 in 2016.
  • Per Business Quant, the three most recent readings for GYRE's Debt Ratio are 0.0 (Q3 2016), 0.0 (Q2 2016), and 0.0 (Q1 2016).